The Effect of Rigid Taping in Chronic Stroke Patients With Knee Hyperextension

Sponsor
Hacettepe University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05679700
Collaborator
(none)
32
1
1
2.3
13.7

Study Details

Study Description

Brief Summary

In this study, it is aimed to examine the effect of rigid taping on hyperextension control in stroke patients with knee hyperextension in the stance phase of gait.

Hypothesis Ho: Rigid taping has no effect on the control of knee hyperextension in stroke patients.

H1: Rigid taping has an effect on the control of knee hyperextension in stroke patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Rigid Taping
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
32 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Rigid Taping in Chronic Stroke Patients With Knee Hyperextension
Actual Study Start Date :
Dec 20, 2022
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Chronic stroke patients with knee hyperextension

Other: Rigid Taping
Rigid taping was applied to stroke patients with knee hyperextension.

Outcome Measures

Primary Outcome Measures

  1. Vicon Motion Capture System [Baseline]

    A total of 16 reflective signs will be placed on certain anatomical points of the participants. Gait analysis will be performed at a distance of 5 meters from the participants. The three-dimensional positions of the reflective marks will be recorded with the 8-camera Vicon motion capture system.

  2. Blade Software System [Baseline]

    Data obtained from Vicon motion capture system will be processed with Blade software. With the blade software, kinematic data will be obtained in the computer environment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Having had a stroke at least 6 months ago

  • Ambulation with or without a walking aid (walker, cane or tripod)

  • To be between 0-3 points according to the Modified Rankin Scoring

  • Presence of spasticity in any of the lower extremity muscles with a value of at least 1 according to the Modified Ashworth Scale

  • Getting a score of 24 or higher on the Mini Mental Test

  • Presence of hyperextension in the stance phase of gait

Exclusion Criteria:
  • Having more than one stroke history

  • Being diagnosed with dementia

  • Having a previous diagnosis of orthopedic, psychiatric or other neurological disease

  • Having a situation that prevents communication

  • History of surgery or joint contracture involving the lower extremities and gait

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hacettepe University Altındağ Ankara Turkey 06230

Sponsors and Collaborators

  • Hacettepe University

Investigators

  • Study Chair: Kadriye Armutlu, Prof. Dr., Hacettepe University
  • Principal Investigator: Süleyman Korkusuz, MSc, Hacettepe University
  • Study Chair: Mehmet Akif Topçuoğlu, Prof. Dr., Hacettepe University
  • Study Chair: Serdar Arıtan, Asst.Prof, Hacettepe University
  • Study Chair: Nihat Özgören, MSc, Hacettepe University
  • Study Chair: Ali Naim Ceren, Msc, Hacettepe University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Suleyman Korkusuz, Principal Investigator, Hacettepe University
ClinicalTrials.gov Identifier:
NCT05679700
Other Study ID Numbers:
  • KA-22045
First Posted:
Jan 11, 2023
Last Update Posted:
Jan 11, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Suleyman Korkusuz, Principal Investigator, Hacettepe University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2023